Ashvattha Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel hydroxyl dendrimer (HD) therapeutics (HDTs) to treat unmet medical needs in oncology, ophthalmology, and inflammatory diseases.

Biotechnology

Ashvattha Therapeutics

Jeffrey L. Cleland

Christine S.

Steve Maricich

Mark Feng

Jennifer Herber

Jay Z.

Debra Nguyen

Jeannie Skinner

Elizabeth Torrelio

Natacha Le Moan

Jiazhong Zhang

Steve Carlos

Ashvattha Therapeutics' CEO and Executive Team includes Matthew Brewer and 1 others.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at Ashvattha Therapeutics

Board of Directors

Leadership Team